Researchers led by Dr. Alex Lehrer at the University of Hawaii (UH) medical school have successfully developed a vaccine candidate for the Zika virus, showing that it is effective in protecting both mice and now monkeys from the infection.
Dr. Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
Demonstrating the effectiveness of the vaccine candidate in monkeys (non-human primates) is an important milestone because it typically predicts the vaccine will work in humans, enabling further clinical development.
A strong global initiative to battle Zika has produced more than 30 vaccine candidates since outbreaks in 2015-2016 in Brazil linked the infection in some pregnant women to severe birth defects in their newborns. Zika is spread by the bite of infected mosquitos and through sex.
The proposed vaccine reported by scientists at the UH John A. Burns School of Medicine (JABSOM) in the journals Frontiers in Immunologyand mSphere, an open access journal of the American Society for Microbiology, is a recombinant subunit vaccine that uses only a small part (protein) of the Zika virus, produced in insect cells.
“We believe our vaccine candidate shows much promise particularly as it showed to require only two immunizations given three weeks apart and is a potentially safer alternative to other candidates already in clinical trials,” said Dr. Axel Lehrer, JABSOM (Assistant) Professor of Tropical Medicine and Infectious Disease.
Lehrer thinks the vaccine his team proposes might be safer that other candidate vaccines, especially keeping in mind that pregnant women constitute a significant part of the target population for a Zika vaccine.
The research team at JABSOM included two senior graduate students who served as lead authors of the scientific research papers. Liana Medina, whose early training was directly supported by a National Institutes of Health Diversity in Health-Related Research grant, and Honolulu native Albert To are the graduate student lead authors.
Honolulu-based Hawai’i Biotech is a key partner in the vaccine development project with UH. Two of their scientists, Dr. Jaime Horton and David Clements, contributed to the most recent publication demonstrating vaccine efficacy in monkeys, along with collaborators from Bioqual Inc. of Rockville, Maryland, and the Department of Diagnostic Medicine/Pathobiology, Biosecurity Research Institute, College of Veterinary Medicine, at Kansas State University.
“The intense search for a Zika remedy since early 2016 has required us to be agile, and we believe our vaccine candidate research demonstrates that such quick-turnaround results can be achieved in academic and scientific partnerships here in Hawai’i,” said Dr. Lehrer. “It is incredibly gratifying that two of the scientists we are training to be the future of biomedical science played key roles in gathering, analyzing and reporting their conclusions. We hope Hawai’i’s citizens find that as inspiring as we do.”
Graduate student scientist and research co-author Liana Medina said there were chances to develop new skills at every step along the way. “Having the opportunity to see the vaccine’s development from its very first stages as Zika E protein being produced by Dr. Kenji Obadia, at the time also a student in our department, to a vaccine that is efficacious and safe in animal models was a unique learning experience. Being a part of the process allowed me grow as a student in this field,” said Medina.
Fellow graduate student and co-author Albert To said the team’s results “put us on the world-stage and highlight the talent we have here in Hawai?i.” He said, “Being involved with this project has given me a glimpse of the type of research and results needed to progress an idea to a potential preventative therapy used by thousands of people worldwide.”
The Latest on: Zika virus
via Google News
The Latest on: Zika virus
- Zika Virus Vaccines Market Will Reflect Significant Growth Prospects during 2019 to 2026on June 23, 2019 at 11:39 pm
Jun 24, 2019 (Global QYResearch via COMTEX) -- The Global Zika Virus Vaccines Market size was valued USD XX million in 2018 and is projected to reach the market value of around USD XX million and ... […]
- Portable device detects dengue, Zika in individual mosquitoeson June 22, 2019 at 4:17 pm
SAN FRANCISCO — Researchers developed a highly sensitive quantitative PCR, or qPCR, method for the detection and quantitation of dengue and Zika virus in individual mosquitoes using the portable Hyris ... […]
- West Nile virus case confirmed in Kalamazoo Countyon June 21, 2019 at 2:24 pm
The Kalamazoo County Environmental Health Division’s vector surveillance program is trapping mosquitoes in five locations throughout the county to identify emergent disease-causing pathogens such as ... […]
- Ontera creates test for Zika virus under $1 million contract with the office of the Director of National Intelligenceon June 20, 2019 at 11:18 pm
SANTA CRUZ– Biotech company Ontera Inc. will develop a genotyping test for diagnosing Zika virus, thanks to a nearly $1 million contract from the Office of the Director of National Intelligence. ... […]
- West Nile Virus: What is West Nile Virus, what are the symptoms and is it FATAL?on June 19, 2019 at 7:52 am
Wile Nile Virus (WNV) is a single-stranded RNA virus from the flavivirus genus and Falvaviridae family - also home to the Zika virus and yellow fever virus. The first known human case was in Uganda in ... […]
- Zika Virus Therapeutics Market Worth USD 33.21 Million, at 4% CAGR During 2019-2023 | Technavioon June 19, 2019 at 4:45 am
According to Technavio Research Report " Zika Virus Therapeutics Market by product (acetaminophen, and other NSAIDs) and geographic regions (ROW, North America, Asia, and Europe) is witnessed to grow ... […]
- Zika Virus Market Spotlight 2019: Key Pipeline Therapies, Clinical Trials, and Licensing and Acquisition Deals - ResearchAndMarkets.comon June 18, 2019 at 8:31 am
DUBLIN--(Business Wire)--The "Market Spotlight: Zika Virus" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers the Zika virus market, comprising key ... […]
- Ontera Awarded ~$1M Contract from IARPA for Zika Genotyping Teston June 18, 2019 at 4:38 am
The funding will support Ontera’s development of a genotyping test to enable fast and accurate diagnosis of individuals infected with Zika virus. There is a critical need for Zika diagnostics to ... […]
- Health Dept.: Learn the signs, how to protect yourself from Zika viruson June 14, 2019 at 8:03 am
The Zika virus is spread through mosquito bites of the Aedes species. These mosquitoes bite both during the day and during the night. Right now, there are no known cases of Zika in the United States. ... […]
via Bing News